Takeda Pharmaceutical (TAK) Buildings (2017 - 2019)

Takeda Pharmaceutical's Buildings history runs 3 years deep, the most recent figure standing at $1.1 billion for Q1 2019.

• In Q1 2019, Buildings changed N/A year-over-year to $1.1 billion; the TTM figure through Mar 2019 stood at $1.1 billion (changed N/A YoY), while the FY2019 annual figure was $1.1 billion, changed N/A from the prior year.
• Buildings was $1.1 billion for Q1 2019 at Takeda Pharmaceutical, down from $2.9 billion in the prior quarter.
• In the past five years, Buildings ranged from a high of $2.9 billion in Q4 2018 to a low of $1.1 billion in Q1 2019.
• Historically, Buildings has averaged $2.0 billion across 3 years, with a median of $1.9 billion in 2017.
• Biggest YoY gain for Buildings was 51.69% in 2018; the steepest drop was 51.69% in 2018.
• A 3-year view of Buildings shows it stood at $1.9 billion in 2017, then soared by 51.69% to $2.9 billion in 2018, then plunged by 61.19% to $1.1 billion in 2019.
• The last three Buildings figures came in at $1.1 billion (Q1 2019), $2.9 billion (Q4 2018), and $1.9 billion (Q4 2017), per Business Quant data.